SEC Form 4 · accession 0001205703-26-000030
INCYTE CORP · INCY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pablo J Cagnoni
Officer — President, Global Head of R&D
Period of report
Sep 15, 2026
Accepted (ET)
Sep 17, 2026 · 4:04 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0000879169
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 15, 2026 | M | 2,957 | $61.76 | A | 186,157 | D | |
| Common Stock | Sep 15, 2026 | M | 4,551 | $61.18 | A | 190,708 | D | |
| Common Stock | Sep 15, 2026 | M | 6,477 | $64.25 | A | 197,185 | D | |
| Common Stock | Sep 15, 2026 | M | 9,233 | $71.93 | A | 206,418 | D | |
| Common Stock | Sep 15, 2026 | S | 9,233 | $120.50 | D | 197,185 | D | |
| Common StockF1 | Sep 15, 2026 | S | 13,985 | $120.49 | D | 183,200 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $61.76 | Sep 15, 2026 | M | 2,957 | D | — | Jul 13, 2033 | Common Stock | 2,957 | 4,225 | D |
| Employee Stock Option (right to buy)F3 | $61.18 | Sep 15, 2026 | M | 4,551 | D | — | Jan 17, 2034 | Common Stock | 4,551 | 4,551 | D |
| Employee Stock Option (right to buy)F4 | $64.25 | Sep 15, 2026 | M | 6,477 | D | — | Jul 14, 2034 | Common Stock | 6,477 | 20,356 | D |
| Employee Stock Option (right to buy)F5 | $71.93 | Sep 15, 2026 | M | 9,233 | D | — | Jan 16, 2035 | Common Stock | 9,233 | 18,466 | D |
Explanation of responses
- F1This includes an aggregate of 183,200 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.
- F2The July 14, 2023 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
- F3Beginning January 18, 2024, options become exercisable in 37 installments, with the first 25% vesting on July 14, 2024 and the remainder vesting monthly over three years.
- F4The July 15, 2024 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
- F5Beginning January 17, 2025, options become exercisable in 37 installments, with the first 25% vesting on July 15, 2025 and the remainder vesting monthly over three years.